Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
about
Botulinum toxins for the prevention of migraine in adultsNeuromodulators for pain management in rheumatoid arthritisNeuromodulators for pain management in rheumatoid arthritisRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateSpotlight on botulinum toxin and its potential in the treatment of stroke-related spasticityCurrent status and future directions of botulinum neurotoxins for targeting pain processingBotulinum Toxin for Neuropathic Pain: A Review of the LiteratureThe Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee PainThe Rehabilitation of Oncological Patients Presenting NeuropathiesBotulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-RehabilitationThe management of diabetic neuropathy in CKD.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.Diabetic neuropathy: clinical manifestations and current treatments.Therapeutic use of botulinum toxin in migraine: mechanisms of action.Treatment of painful diabetic neuropathyIntraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial.Burning through the pain: treatments for diabetic neuropathy.Botulinum toxin therapy for osteoarticular pain: an evidence-based reviewPharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.A robust approach for identifying differentially abundant features in metagenomic samplesEfficient assessment of efficacy in post-traumatic peripheral neuropathic pain patients: pregabalin in a randomized, placebo-controlled, crossover studyClinical uses of botulinum neurotoxins: current indications, limitations and future developmentsA review of thoracic outlet syndrome and the possible role of botulinum toxin in the treatment of this syndromeUltrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain.Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.Treatment of Morton neuroma with botulinum toxin A: a pilot study.Use of botulinum toxin in musculoskeletal pain.Botulinum toxin injection in neurogenic thoracic outlet syndrome: results and experience using a ultrasound-guided approach.Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy.Pharmacological treatment of diabetic neuropathic pain.Treatment of refractory pain with botulinum toxins--an evidence-based review.Diabetic neuropathy and oxidative stress: therapeutic perspectives.OnabotulinumtoxinA for the treatment of headache.More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
P2860
Q24186932-CC55C68C-44DD-42BA-9FC2-E3107100E3D9Q24203885-317745FF-3470-48C7-A018-788AF5557E6CQ24235149-F128EBDC-BCD0-452E-854D-BA8C45C947E5Q24616897-A0A0449C-157A-4AC6-B308-CA64A88FE70BQ26750450-736C3416-4AE5-4597-82E3-BDAE9488B4BBQ26778129-0E79491B-1F5D-4FFA-9D9B-F0610884310CQ26796604-B9996471-61D4-4D9A-A548-D4739ECAE34EQ26797317-7B462327-1929-488C-AC31-6F1945135361Q27024318-6D4A6164-3F4A-4189-9A6B-3524C2836118Q28088625-6D8D7B27-5404-47B9-B4E3-A21D149C2E71Q33554396-09EBBF15-66E9-40F3-9E65-90F72198C54EQ33583006-6A817988-11CE-4E7B-90BF-303107319D11Q33828749-E3B98DA5-9049-4A02-A9FB-EA1563980A76Q34110857-886AC9F0-671F-40B9-B0AC-3A5E20C6C785Q34154494-A13DD30E-7802-42F5-B507-90BA1EB861D4Q34275990-826B8199-08A1-49B0-881D-44884E6B1281Q34419654-829E2FF0-2BE0-44AF-92A8-1E4A9B1A3950Q34456265-07787BB5-DF4E-4481-895E-E372375C110BQ34479556-AE63A1F5-582C-4306-AFA2-0793BB8BEE3EQ34485306-6C70015F-033A-4148-8E89-1BE6CCA67113Q34554147-979B776B-C6EE-44ED-B686-2539667874CBQ34756198-0D32AE0C-74B2-4A52-8C48-1CB7328A2159Q35584564-0EC01399-FEEF-483A-A7B0-809566D23625Q35691221-667AC17B-72B0-4215-A9DB-595CD48DDB62Q35829702-166D615C-241A-417E-9DB4-35B4B08633E8Q36145852-26315170-B251-4F79-B225-5FAE742608D1Q36395728-506C5CBF-5915-4686-AB61-1D8DA402F58EQ36432805-5C74C102-465B-4870-9388-E8969FA53FDDQ36507197-AD41C2D0-F7D7-49A5-8253-ACFACD15EDD2Q36780108-F62718EE-9929-4F0C-9CAC-4CF3B7E8AC47Q36952082-50281917-827A-4679-82E7-E73FE7DCCB58Q37671002-BD826C97-9C2D-4297-9C29-B36EF6D83EB9Q37698986-DC66C0FE-629C-4C8D-8C7B-0BB5C1A70DCFQ37700722-574D1572-7C29-4386-8618-17581AA25064Q37723197-E40D3763-E5EC-43CF-AE15-E681773AC239Q37858519-95994A55-9EDC-4121-9047-46B6F28EDA69Q37940623-24B555A5-CD8D-4092-BB00-60F8C9155B24Q38112117-69EABD9B-8E8E-4F6D-ABFA-73F3C3D62AE6Q38136258-4D8091B5-9B1D-4414-913A-08EDBB6B47AAQ38191755-3F8C4894-C273-4B63-BD3F-C99F4BC7945F
P2860
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
@en
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
@nl
type
label
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
@en
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
@nl
prefLabel
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
@en
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
@nl
P2093
P1433
P1476
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
@en
P2093
P304
P356
10.1212/01.WNL.0000345968.05959.CF
P407
P577
2009-02-25T00:00:00Z